Top 25 Companies in Global Anti-Inflammatory Drugs Market (2024–2035): Competitive Analysis & Forecast

Description

According to a research report published by Spherical Insights & Consulting, the Global Anti-Inflammatory Drugs Market Size is projected to grow from USD 121.7 billion in 2024 to USD 302.1 billion by 2035, at a CAGR of 8.62% during the forecast period 2024-2035. The global anti-inflammatory drugs market is driven by the rising prevalence of chronic inflammatory diseases, increasing aging population, growing demand for pain management therapies, advancements in drug development, and expanding healthcare infrastructure worldwide.

 

Introduction

 

The global anti-inflammatory drugs market refers to the pharmaceutical sector focused on drugs that reduce inflammation, pain, and immune responses in conditions such as arthritis, asthma, and inflammatory bowel disease. These include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologics. The market is expanding steadily, projected to grow at around 8–9% CAGR due to the rising burden of chronic inflammatory diseases and increasing aging population worldwide.

 

Key drivers include growing prevalence of autoimmune and lifestyle-related disorders, technological advancements in targeted therapies, and increasing R&D investments. Opportunities lie in biologics, personalized medicine, and advanced drug delivery systems. Recent developments include new drug approvals such as celecoxib capsules in 2025 and strong demand for biologics like Dupixent, alongside innovations like AI-developed anti-inflammatory drugs entering late-stage trials, highlighting rapid industry evolution.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

 

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti-Inflammatory Drugs Market.

 

Global Anti-Inflammatory Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Biologics, Other Drug Classes), By Disease Type (Rheumatoid Arthritis, Osteoarthritis, Psoriasis, Inflammatory Bowel Disease, Asthma, Other Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Injectable, Topical, Inhalation), By End User (Hospitals, Clinics, Homecare, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, Africa), Analysis and Forecast 2024–2035.

 

Anti-Inflammatory Drugs Market Size & Statistics

 

• The Market Size for Anti-Inflammatory Drugs Was Estimated to be worth USD 121.7 billion in 2024.

• The Market is Going to Expand at a CAGR of 62% between 2024 and 2035.

• The Global Anti-Inflammatory Drugs Market Size is anticipated to reach USD 302.1 billion by 2035.

• North America is expected to generate the highest demand during the forecast period in the Anti-Inflammatory Drugs Market

• Asia Pacific is expected to grow the fastest during the forecast period in the Anti-Inflammatory Drugs Market.

 

Regional growth and demand

                                    

Asia Pacific is expected to grow the fastest during the forecast period in the Anti-Inflammatory Drugs market. Asia Pacific is expected to grow fastest due to rising healthcare expenditure, increasing prevalence of chronic inflammatory diseases, large patient population, improving access to biologics, and expanding pharmaceutical manufacturing in emerging economies.

 

North America is expected to generate the highest demand during the forecast period in the Anti-Inflammatory Drugs market. North America is expected to generate the highest demand due to advanced healthcare infrastructure, high adoption of biologics, strong R&D investments, rising autoimmune disease prevalence, and presence of leading pharmaceutical companies.

 

 

Top 10 Trends in the Anti-Inflammatory Drugs Market

 

• Shift toward biologics and targeted therapies
• Growth of personalized/precision medicine
• Rising adoption of oral small-molecule drugs
• Expansion of biosimilars to reduce costs
• Increasing R&D and AI-driven drug discovery
• Growing prevalence of autoimmune diseases
• Strong pipeline of next-generation biologics
• Rising OTC (over-the-counter) drug demand
• Expansion in emerging markets (Asia-Pacific)
• Improved drug delivery systems and patient adherence

 

1. Shift toward biologics and targeted therapies

The market is rapidly transitioning from traditional NSAIDs and corticosteroids to biologics and targeted immunotherapies. These drugs act on specific cytokines and immune pathways, offering higher efficacy and fewer side effects. This shift is especially prominent in treating severe autoimmune diseases like rheumatoid arthritis and psoriasis.

 

2. Growth of personalized/precision medicine

Personalized medicine is gaining traction through biomarker-based diagnostics and tailored treatments. Physicians now select therapies based on patient-specific disease pathways, improving outcomes and reducing adverse effects. This trend enhances treatment efficiency and supports the development of precision immunology solutions across multiple inflammatory conditions.

 

3. Rising adoption of oral small-molecule drugs

New oral therapies such as JAK and TYK2 inhibitors are expanding treatment options. These drugs provide convenience compared to injectable biologics, improving patient compliance. Their ability to target specific immune pathways while offering easier administration is driving strong demand globally.

 

4. Expansion of biosimilars to reduce costs

Biosimilars are emerging as cost-effective alternatives to expensive biologics. Regulatory support and patent expirations are accelerating their adoption. This trend improves accessibility for patients and reduces healthcare costs, especially in developing markets where affordability remains a key challenge.

 

5. Increasing R&D and AI-driven drug discovery

Pharmaceutical companies are heavily investing in R&D and AI-based drug discovery. AI is accelerating clinical trials and identifying novel anti-inflammatory targets. Recent innovations, including AI-developed drugs entering late-stage trials, are expected to significantly transform treatment effectiveness and speed up market growth.

 

        6. Local Value Addition:

 

There’s growing emphasis on beneficiation and downstream processing to retain more economic value domestically, create jobs, and foster industrial growth.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Anti-Inflammatory Drugs market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti-Inflammatory Drugs Market.

 

Top 25 Companies Leading the Anti-Inflammatory Drugs Market

1. Johnson & Johnson
2. Pfizer
3. AbbVie
4. Roche
5. AstraZeneca
6. Amgen
7. Novartis
8. Merck & Co.
9. Sanofi
10. GlaxoSmithKline
11. Bristol-Myers Squibb
12. Eli Lilly and Company
13. Gilead Sciences
14. Regeneron Pharmaceuticals
15. Bayer
16. Boehringer Ingelheim
17. Teva Pharmaceutical Industries
18. UCB
19. Viatris
20. Sun Pharmaceutical Industries
21. Reddy’s Laboratories
22. Haleon
23. Reckitt Benckiser
24. Perrigo Company
25. Horizon Therapeutics

 

1. Johnson & Johnson

Headquarters: New Brunswick, New Jersey, USA

Johnson & Johnson is a global leader in immunology and anti-inflammatory therapies, with strong biologics targeting autoimmune diseases like rheumatoid arthritis and psoriasis. Its diversified healthcare portfolio and global distribution network support sustained leadership, driven by continuous innovation, clinical research, and expansion of advanced biologic treatments.

 

2. Pfizer

Headquarters: New York, USA

Pfizer plays a major role in anti-inflammatory drugs through NSAIDs and advanced immunology therapies. The company invests heavily in R&D and acquisitions to expand its inflammation pipeline, including treatments for autoimmune diseases. Its global presence and strong commercialization capabilities strengthen its competitive position.

 

3. AbbVie

Headquarters: North Chicago, Illinois, USA

AbbVie is a dominant player in immunology, driven by blockbuster anti-inflammatory drugs like Skyrizi and Rinvoq. The company focuses on precision medicine and biologics to treat chronic inflammatory diseases, maintaining strong market share through innovation, robust clinical pipelines, and strategic expansion in autoimmune therapies.

 

4. Roche

Headquarters: Basel, Switzerland

Roche specializes in biologics and personalized healthcare solutions for inflammatory diseases. Its key therapy Actemra is widely used in rheumatoid arthritis and systemic inflammation. The company integrates diagnostics with therapeutics, enhancing treatment precision and strengthening its position in the global anti-inflammatory drugs market.

 

5. AstraZeneca

Headquarters: Cambridge, United Kingdom

AstraZeneca focuses on innovative biologics and targeted therapies for inflammatory and respiratory diseases. The company leverages strong R&D capabilities and strategic collaborations to develop next-generation treatments, particularly in immunology and chronic inflammatory conditions, supporting its growing presence in the global anti-inflammatory drug market

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Anti-Inflammatory Drugs Market..

 

Are you ready to discover more about the Anti-Inflammatory Drugs market?

The report provides an in-depth analysis of the leading companies operating in the global anti-inflammatory drugs market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Johnson & Johnson

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

2. Pfizer
3. AbbVie
4. Roche
5. AstraZeneca
6. Amgen
7. Novartis
8. Merck & Co.
9. Sanofi

 

Conclusion

he global anti-inflammatory drugs market is poised for strong growth, driven by rising chronic disease prevalence, aging populations, and continuous innovation in biologics and precision medicine. Advancements in AI-driven drug discovery and increasing accessibility of biosimilars are further accelerating market expansion. Regionally, Asia-Pacific offers significant growth potential, while North America remains the dominant revenue contributor due to advanced healthcare systems and high adoption of innovative therapies. Leading players such as Johnson & Johnson, Pfizer, and AbbVie continue to drive competition through strong R&D and product pipelines. Overall, the market presents substantial opportunities for stakeholders focusing on innovation and global expansion.

 

Other Indusrty Reports : 

North America Preclinical In Vivo Imaging Market Size, Shares, Trend, Forecasts to 2035
South Korea Bioherbicides Market Size, Shares, Trend, Forecasts to 2035
Australia Pen Needles Market Size, Shares, Trend, Forecasts to 2035
Brazil Clear Aligner Market Size, Shares, Trend, Forecasts to 2035 

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter